Tags

Type your tag names separated by a space and hit enter

Hepatitis B vaccination coverage among adults aged ≥18 years traveling to a country of high or intermediate endemicity, United States, 2015.
Vaccine. 2018 Apr 28 [Online ahead of print]V

Abstract

BACKGROUND

Persons from the United States who travel to developing countries are at substantial risk for hepatitis B virus (HBV) infection. Hepatitis B vaccine has been recommended for adults at increased risk for infection, including travelers to high or intermediate hepatitis B endemic countries.

PURPOSE

To assess hepatitis B vaccination coverage among adults ≥18 years traveling to a country of high or intermediate endemicity from the United States.

METHODS

Data from the 2015 National Health Interview Survey (NHIS) were analyzed to determine hepatitis B vaccination coverage (≥1 dose) and series completion (≥3 doses) among persons aged ≥18 years who reported traveling to a country of high or intermediate hepatitis B endemicity. Multivariable logistic regression and predictive marginal analyses were conducted to identify factors independently associated with hepatitis B vaccination.

RESULTS

In 2015, hepatitis B vaccination coverage (≥1 dose) among adults aged ≥18 years who reported traveling to high or intermediate hepatitis B endemic countries was 38.6%, significantly higher compared with 25.9% among non-travelers. Series completion (≥3 doses) was 31.7% and 21.2%, respectively (P < 0.05). On multivariable analysis among all respondents, travel status was significantly associated with hepatitis B vaccination coverage and series completion. Other characteristics independently associated with vaccination (≥1 dose, and ≥3 doses) among travelers included age, race/ethnicity, educational level, duration of US residence, number of physician contacts in the past year, status of ever being tested for HIV, and healthcare personnel status.

CONCLUSIONS

Although travel to a country of high or intermediate hepatitis B endemicity was associated with higher likelihood of hepatitis B vaccination, hepatitis B vaccination coverage was low among adult travelers to these areas. Healthcare providers should ask their patients about travel plans and recommend and offer travel related vaccinations to their patients or refer them to alternate sites for vaccination.

Authors+Show Affiliations

Immunization Services Division, National Center for Immunization and Respiratory Diseases, United States. Electronic address: lhp8@cdc.gov.Immunization Services Division, National Center for Immunization and Respiratory Diseases, United States.Immunization Services Division, National Center for Immunization and Respiratory Diseases, United States.Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

29716773

Citation

Lu, Peng-Jun, et al. "Hepatitis B Vaccination Coverage Among Adults Aged ≥18 Years Traveling to a Country of High or Intermediate Endemicity, United States, 2015." Vaccine, 2018.
Lu PJ, O'Halloran AC, Williams WW, et al. Hepatitis B vaccination coverage among adults aged ≥18 years traveling to a country of high or intermediate endemicity, United States, 2015. Vaccine. 2018.
Lu, P. J., O'Halloran, A. C., Williams, W. W., & Nelson, N. P. (2018). Hepatitis B vaccination coverage among adults aged ≥18 years traveling to a country of high or intermediate endemicity, United States, 2015. Vaccine. https://doi.org/10.1016/j.vaccine.2018.03.031
Lu PJ, et al. Hepatitis B Vaccination Coverage Among Adults Aged ≥18 Years Traveling to a Country of High or Intermediate Endemicity, United States, 2015. Vaccine. 2018 Apr 28; PubMed PMID: 29716773.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hepatitis B vaccination coverage among adults aged ≥18 years traveling to a country of high or intermediate endemicity, United States, 2015. AU - Lu,Peng-Jun, AU - O'Halloran,Alissa C, AU - Williams,Walter W, AU - Nelson,Noele P, Y1 - 2018/04/28/ PY - 2018/01/11/received PY - 2018/03/09/revised PY - 2018/03/13/accepted PY - 2018/5/3/entrez PY - 2018/5/3/pubmed PY - 2018/5/3/medline KW - Adults at risk KW - Coverage KW - Hepatitis B KW - Hepatitis B vaccine KW - Travel status KW - Vaccination JF - Vaccine JO - Vaccine N2 - BACKGROUND: Persons from the United States who travel to developing countries are at substantial risk for hepatitis B virus (HBV) infection. Hepatitis B vaccine has been recommended for adults at increased risk for infection, including travelers to high or intermediate hepatitis B endemic countries. PURPOSE: To assess hepatitis B vaccination coverage among adults ≥18 years traveling to a country of high or intermediate endemicity from the United States. METHODS: Data from the 2015 National Health Interview Survey (NHIS) were analyzed to determine hepatitis B vaccination coverage (≥1 dose) and series completion (≥3 doses) among persons aged ≥18 years who reported traveling to a country of high or intermediate hepatitis B endemicity. Multivariable logistic regression and predictive marginal analyses were conducted to identify factors independently associated with hepatitis B vaccination. RESULTS: In 2015, hepatitis B vaccination coverage (≥1 dose) among adults aged ≥18 years who reported traveling to high or intermediate hepatitis B endemic countries was 38.6%, significantly higher compared with 25.9% among non-travelers. Series completion (≥3 doses) was 31.7% and 21.2%, respectively (P < 0.05). On multivariable analysis among all respondents, travel status was significantly associated with hepatitis B vaccination coverage and series completion. Other characteristics independently associated with vaccination (≥1 dose, and ≥3 doses) among travelers included age, race/ethnicity, educational level, duration of US residence, number of physician contacts in the past year, status of ever being tested for HIV, and healthcare personnel status. CONCLUSIONS: Although travel to a country of high or intermediate hepatitis B endemicity was associated with higher likelihood of hepatitis B vaccination, hepatitis B vaccination coverage was low among adult travelers to these areas. Healthcare providers should ask their patients about travel plans and recommend and offer travel related vaccinations to their patients or refer them to alternate sites for vaccination. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/29716773/Hepatitis_B_vaccination_coverage_among_adults_aged_≥18_years_traveling_to_a_country_of_high_or_intermediate_endemicity_United_States_2015_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(18)30376-1 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.